Alvotech (ALVO) Change in Cash (2022 - 2026)
Alvotech (ALVO) posted Change in Cash of -$107.6 million for Q1 2026, down 192.41% on a QoQ basis from $116.4 million in Q4 2025, and down 686.2% year-over-year from $18.4 million in Q1 2025.
Alvotech (ALVO) Change in Cash (2022 - 2026) Analysis & Trends
Alvotech's Change in Cash history runs 5 years deep, the most recent figure standing at -$107.6 million for Q1 2026.
- Quarterly Change in Cash fell 686.2% year-over-year to -$107.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.5 million (up 236.89% YoY) and the FY2025 annual result came in at $116.4 million, up 179.89% from the prior year.
- Change in Cash was -$107.6 million for Q1 2026 at Alvotech, down from $116.4 million in the prior quarter.
- Across five years, Change in Cash topped out at $116.4 million in Q4 2025 and bottomed at -$107.6 million in Q1 2026.
- A 5-year average of $20.0 million and a median of $47.2 million in 2023 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 305.44% in 2025, while the deepest fall reached 19014.3% in 2025.
- Alvotech's Change in Cash stood at $66.4 million in 2022, then changed by 0.0% to $66.4 million in 2023, then declined by 22.58% to $51.4 million in 2024, then jumped by 126.4% to $116.4 million in 2025, then sank by 192.41% to -$107.6 million in 2026.
- Business Quant data shows ALVO's Change in Cash at -$107.6 million in Q1 2026, $116.4 million in Q4 2025, and -$96.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | -107.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -107.59 Mn |
| Dec 31, 2025 | 116.43 Mn |
| Sep 30, 2025 | -96.61 Mn |
| Jun 30, 2025 | 110.29 Mn |
| Mar 31, 2025 | -13.69 Mn |
| Dec 31, 2024 | 51.43 Mn |
| Sep 30, 2024 | -505,447.00 |
| Jun 30, 2024 | -53.68 Mn |
| Mar 31, 2024 | 54.30 Mn |
| Dec 31, 2023 | 66.43 Mn |
| Jun 30, 2023 | 19.25 Mn |
| Mar 31, 2023 | 47.18 Mn |
| Dec 31, 2022 | 66.43 Mn |